This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
7877 |
4. Check minimum number of events
Min. number of events
3
|
7877 |
5. Include endpointsNone |
7877 |
6. Filter based on genotype QC (FinnGen only) |
7206 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
L02BA Anti-estrogens
based on the number of shared cases.
Similar with more cases:
- Medicines for HER+ breast cancer
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 7206 | 7071 | 135 |
| Unadjusted period prevalence (%) | 2.46 | 2.51 | 0.06 |
| Median age at first event (years) | 55.74 | 55.57 | 64.48 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7440
- Matched controls
- 74388
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
10.5
314.7
352
349
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
310.6
3666
20995
H02AB02
ATC
dexamethasone; systemic
15.2
307.7
3954
5180
FM1FN
NOMESCO Finland
Heart function isotope examination
21.6
307.7
287
138
A04AD12
ATC
aprepitant; systemic
14.8
307.7
929
710
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
7.1
307.7
751
1165
A03FA01
ATC
metoclopramide; systemic, rectal
7.8
307.7
4630
12954
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
15.1
307.7
1476
1200
C50.99
ICD-10 Finland
Breast, unspecified
18.6
307.7
1767
1227
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
32.5
307.7
429
140
A04AA55
ATC
palonosetron, combinations; systemic
11.6
307.7
1538
1628
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.4
307.7
1509
1963
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
31.6
307.7
230
75
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
10.6
307.7
1372
1551
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
13.6
307.7
505
397
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
22.6
307.7
637
307
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
15.1
307.7
806
595
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
20.0
307.7
448
237
ZX090
NOMESCO Finland
Other technic of radiotherapy
12.1
307.7
824
756
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
13.0
307.7
733
621
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
10.4
307.7
1156
1289
HAB40
NOMESCO Finland
Wedge excision of mammary gland
14.7
307.7
2673
2738
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
24.8
307.7
229
95
115
Kela drug reimbursment
Breast cancer
687.9
307.7
7266
4257
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
16.9
307.7
2282
1902
394
Kela drug reimbursment
Palbociclib
89.6
307.7
533
64
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
307.7
3645
19877
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
19.0
307.7
1894
1312
JN4BD
NOMESCO Finland
Extensive body CT
5.6
307.7
1708
3755
M05BX04
ATC
denosumab; parenteral
4.5
307.7
1261
3219
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
30.3
307.7
2803
1456
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
14.4
307.7
984
779
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
16.9
307.7
861
573
C50
ICD-10 Finland
Malignant neoplasm of breast
17.2
307.7
1504
1079
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
19.9
307.7
391
207
R4110
NOMESCO Finland
Physiotherapy
3.0
307.7
3186
14997
1501
Kela drug reimbursment
Palbociclib
91.9
307.7
577
68
L01BC06
ATC
capecitabine; oral
6.7
307.7
773
1270
N63
ICD-10 Finland
Unspecified lump in breast
3.7
307.7
1273
3906
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
29.3
307.7
958
373
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
30.2
307.7
1483
609
X76
ICPC
Malignant neoplasm breast female
19.1
307.7
1266
790
ZZR10
NOMESCO Finland
Flap of skin and muscle
16.4
307.7
343
219
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
7.7
307.7
479
655
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
15.7
307.7
302
200
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
22.0
307.7
949
490
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
23.9
307.7
243
105
HAB99
NOMESCO Finland
Other partial excision of mammary gland
7.1
307.7
790
1231
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
10.5
307.7
2026
2552
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
23.3
307.7
3158
2285
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.4
307.7
1369
3609
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
13.7
307.7
353
269
HAE99
NOMESCO Finland
Other reconstruction of breast
23.0
307.7
496
230
L01EF01
ATC
palbociclib; oral
84.9
307.7
356
44
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
12.3
307.7
1072
1007
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
18.7
307.7
1290
824
ZX120
NOMESCO Finland
Intravenous
4.9
307.7
1541
3761
A04AA01
ATC
ondansetron; systemic, rectal
4.8
307.7
1596
4034
L02BA01
ATC
tamoxifen; oral
4291.7
307.7
7125
390
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
8.7
307.7
782
990
L02BG04
ATC
letrozole; oral
19.3
307.7
3640
3526
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
10.1
307.7
669
720
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
10.4
307.7
385
387
A04AA02
ATC
granisetron; systemic, transdermal
11.4
307.7
2063
2416
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.0
307.7
3026
10809
192
Kela drug reimbursment
Fulvestrant
1330.9
307.7
722
6
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
5.3
307.7
931
1957
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.7
307.7
964
1023
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
29.2
307.7
3990
2838
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
14.8
307.7
1162
921
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.9
307.7
679
936
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
19.0
307.7
294
161
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.1
307.7
763
1184
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
22.3
307.7
335
157
L02BA03
ATC
fulvestrant; parenteral
689.2
307.7
908
15
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
9.6
307.7
398
437
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
17.1
307.7
799
520
L03AA02
ATC
filgrastim; parenteral
7.3
307.7
642
946
L03AA13
ATC
pegfilgrastim; parenteral
12.8
307.7
1850
1882
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
16.1
307.7
571
381
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
18.7
307.7
1007
619
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
18.0
307.7
950
599
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
16.4
307.7
823
561
NK6AN
NOMESCO Finland
Total body bone isotope imaging
16.8
307.7
788
521
ZX112
NOMESCO Finland
Subcutaneous
8.8
307.7
470
563
1CD02, ,
NOMESCO Finland
42.4
307.7
655
169
L01CA04
ATC
vinorelbine; systemic
20.6
307.7
335
170
TQW20
NOMESCO Finland
Tatoe
28.8
307.7
799
310
XX3DW
NOMESCO Finland
Time consuming IT work
4.0
307.7
1557
4566
HAC20
NOMESCO Finland
Total mastectomy
24.4
307.7
2818
1810
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
15.7
307.7
845
604
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
26.7
307.7
1096
478
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
27.6
307.7
297
112
L03AA14
ATC
lipegfilgrastim; parenteral
7.4
307.7
505
728
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
29.2
307.7
1145
460
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
11.3
307.7
997
1006
ZZF00
NOMESCO Finland
Graft of adipose tissue
17.5
307.7
401
241
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
15.0
307.7
2265
2105
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
15.1
307.7
3451
4027
L02AE03
ATC
goserelin; implant
14.3
307.7
363
266
PJA12
NOMESCO Finland
Sentinel node biopsy
22.2
307.7
4331
4398
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
17.8
307.7
341
200
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
17.5
307.7
285
169
L02BG06
ATC
exemestane; oral
25.3
307.7
1289
610
HA1AA
NOMESCO Finland
X-ray mammography
16.8
307.7
4036
4896
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
22.6
307.7
247
113
Z31.5
ICD-10 Finland
Genetic counselling
6.2
307.7
1206
2259
L02BG03
ATC
anastrozole; oral
17.3
307.7
921
602
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
22.6
307.7
279
128
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
20.3
307.7
255
130
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
12.6
307.7
338
280
A79
ICPC
Malignancy NOS
10.8
307.7
413
403
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
30.8
307.7
316
107
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.2
307.7
4919
23711
L01XE33
ATC
[U] palbociclib
101.0
307.7
347
36
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
12.6
307.6
304
250
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.3
304.1
654
1335
ZX080
NOMESCO Finland
Image guided radiotherapy
7.0
303.7
480
727
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.5
300.4
397
490
1XC03, ,
NOMESCO Finland
25.9
298.0
207
82
ZXA05
NOMESCO Finland
Left side
2.6
295.7
2563
12666
L01EF03
ATC
abemaciclib; oral
39.6
285.4
174
45
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.2
285.1
326
333
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
17.9
284.2
231
133
3030
Kela drug reimbursment
Abemaciclib
39.3
283.3
173
45
HAC25
NOMESCO Finland
Radical mastectomy
18.7
281.8
224
123
1515, ,
Kela drug reimbursment
38.5
281.7
173
46
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
16.4
278.2
236
148
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.1
270.9
609
1289
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
17.2
270.4
224
134
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.3
268.9
305
308
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
18.8
267.1
212
116
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
26.4
265.3
183
71
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
13.3
263.6
252
196
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
16.5
262.8
222
138
HAD40
NOMESCO Finland
Mastopexy
15.2
260.9
231
157
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
26.3
260.7
180
70
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
5.5
256.2
514
983
M05BA02
ATC
clodronic acid; systemic
29.1
251.9
168
59
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
21.6
249.7
186
88
ZXA00
NOMESCO Finland
Right side
2.3
242.7
2605
13936
HAD99
NOMESCO Finland
Other plastic operation on breast
11.7
235.9
244
215
1514, ,
Kela drug reimbursment
60.6
235.5
131
22
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
16.6
235.4
198
122
3002
Kela drug reimbursment
Ribociclib
63.0
235.2
130
21
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
11.2
232.5
248
229
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
13.7
232.4
218
164
L02AE02
ATC
leuprorelin; implant, parenteral
7.6
232.3
337
463
L01EF02
ATC
ribociclib; oral
55.5
231.7
131
24
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
14.1
228.9
211
154
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
8.0
226.7
314
409
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
11.2
226.2
241
222
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
216.3
3496
21805
Z3226
NOMESCO Finland
Physiotherapist
2.4
215.7
1838
8815
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.7
213.8
350
548
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
4.8
209.6
501
1112
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
11.5
208.4
217
193
N06AX16
ATC
venlafaxine; oral
2.5
207.9
1654
7672
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
12.0
206.6
210
180
TQB05
NOMESCO Finland
Puncture of skin of trunk
8.9
205.5
260
303
WX702
NOMESCO Finland
Supraglottic ventilation device
3.5
202.6
770
2390
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
9.9
202.1
235
245
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
12.0
197.9
201
172
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
7.0
197.8
306
451
HA1HA
NOMESCO Finland
Tomosynthesis mammography
8.7
191.7
245
289
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
21.4
188.8
141
67
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
9.1
188.4
232
261
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
13.2
187.1
179
139
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
17.3
186.8
154
91
Z3231
NOMESCO Finland
Registered nurse
2.1
184.7
2388
13483
JN4AD
NOMESCO Finland
Body CT examination
2.7
176.4
1130
4694
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
12.4
172.3
171
141
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
21.2
171.8
129
62
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
19.3
170.3
133
70
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
10.4
170.2
190
187
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.3
170.0
294
486
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
21.2
169.2
127
61
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
8.2
169.1
228
287
X26
ICPC
Fear of breast cancer female
9.0
165.7
207
237
Z51.5
ICD-10 Finland
Palliative care
2.9
165.4
861
3204
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
13.1
164.0
157
122
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
24.0
162.7
116
49
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
17.2
160.0
132
78
Z51.0
ICD-10 Finland
Radiotherapy session
7.3
159.8
237
333
XX1XN
NOMESCO Finland
Other isotope examination
7.2
159.4
239
340
X21
ICPC
Breast sympt/compl female other
4.4
157.3
415
993
PJW99
NOMESCO Finland
Other operation on lymphatic system
11.1
157.1
167
153
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.7
152.9
515
1470
L02BA02
ATC
toremifene; oral
758.6
151.8
149
*
WF004
NOMESCO Finland
Palliative radiotherapy
5.9
151.3
277
484
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
148.7
483
1344
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
12.6
142.9
140
113
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.8
142.3
266
474
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
141.9
2172
12815
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
134.1
516
1603
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
10.4
132.0
147
144
WX402
NOMESCO Finland
General anaesthesia
2.0
130.9
2016
11863
N84.0
ICD-10 Finland
Polyp of corpus uteri
2.3
130.5
1088
5061
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
7.3
129.3
191
267
N02AA05
ATC
oxycodone; systemic
2.1
128.7
1596
8694
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
18.4
125.3
100
55
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
4.7
125.0
296
649
3AA13, ,
NOMESCO Finland
20.5
124.8
95
47
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
9.7
119.6
140
147
WZC30
NOMESCO Finland
Teaching
2.0
119.6
1486
8075
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
118.6
319
773
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
8.9
117.8
147
168
QBJ00
NOMESCO Finland
Liposuction in trunk
8.6
117.5
151
179
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
9.3
117.0
141
154
LCA06
NOMESCO Finland
Biopsy of endometrium
2.0
115.9
1589
8931
HAD20
NOMESCO Finland
Liposuction of breast
16.6
115.8
97
59
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
3.5
115.5
419
1252
B01AB05
ATC
enoxaparin; parenteral
1.8
110.9
2729
18394
HA1SA
NOMESCO Finland
Expansion mammography
9.2
110.2
134
148
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
109.8
916
4242
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
5.7
109.8
206
368
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
16.4
108.0
91
56
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
11.3
105.5
111
100
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
34.5
102.7
65
19
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
7.5
102.3
147
199
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
102.2
1069
5418
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
101.8
565
2157
R50.9
ICD-10 Finland
Fever, unspecified
2.0
97.8
1193
6395
X19
ICPC
Breast lump/mass female
4.0
97.2
281
718
WF002
NOMESCO Finland
Radical radiotherapy
3.3
96.3
380
1196
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
13.2
93.8
89
68
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
13.2
93.8
89
68
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.8
93.7
213
451
HA1BA
NOMESCO Finland
Extensive X-ray mammography
6.8
93.5
148
223
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.6
92.7
3744
46470
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
9.0
92.6
114
128
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
15.2
91.3
80
53
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
90.4
3556
26709
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.2
89.5
188
372
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.0
88.8
255
648
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
8.9
86.7
108
123
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
15.9
86.3
74
47
L02AB02
ATC
medroxyprogesterone; systemic
6.8
85.0
133
198
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.2
84.8
233
573
A46
ICD-10 Finland
Erysipelas
2.0
84.4
1096
5982
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.4
84.1
312
944
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
6.5
82.3
135
211
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
13.1
81.8
78
60
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
8.0
81.2
110
139
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
14.9
80.1
71
48
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.4
80.0
514
11164
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
9.8
77.8
90
93
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.2
77.1
670
3136
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.0
77.0
225
579
A02BC02
ATC
pantoprazole; systemic
1.7
76.9
5468
46546
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.4
76.0
284
863
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
3.8
75.3
237
643
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
4.9
74.5
164
338
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
4.3
74.0
191
448
ZXE00
NOMESCO Finland
One hour or less
1.6
73.7
2941
21815
Z2221
NOMESCO Finland
Medical doctor
1.6
73.5
2139
14712
JN4CD
NOMESCO Finland
Very extensive body CT
3.1
72.5
318
1064
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
70.9
1849
12353
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.2
70.7
188
451
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
10.1
69.9
79
79
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
6.7
69.8
111
168
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
2.2
69.2
625
2968
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
16.9
68.6
57
34
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
9.6
68.3
80
84
9703
FHL
Breast resection
4.8
68.0
156
333
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.7
67.9
160
349
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
12.6
67.4
66
53
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.3
67.2
525
2346
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
11.6
67.1
69
60
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
10.0
66.6
76
77
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
66.4
595
2815
HA1AE, ,
SPAT
2.6
66.2
419
1701
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
25.7
66.0
46
18
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.4
65.8
248
757
QBA00
NOMESCO Finland
Puncture of skin of trunk
9.0
65.7
81
91
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.7
65.5
123
220
OAA41
NOMESCO Finland
Health check based on individual needs
7.4
63.9
92
125
HAD00
NOMESCO Finland
Augmentation mammoplasty
13.8
63.8
59
43
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
11.7
63.6
65
56
Z31.6
ICD-10 Finland
General counselling and advice on procreation
9.5
63.3
75
80
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
8.3
63.2
83
101
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
3.6
62.7
208
585
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
62.1
445
1912
1XC13, ,
NOMESCO Finland
25.4
61.5
43
17
B01AB10
ATC
tinzaparin; parenteral
1.8
59.8
960
5570
G02CX06, ,
ATC
9.3
59.2
71
77
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
10.6
58.5
64
61
M05BA06
ATC
ibandronic acid; systemic
2.9
58.4
275
958
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
57.2
294
1074
N02BE01
ATC
paracetamol; systemic, rectal
2.0
57.0
6841
63333
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
17.8
56.7
46
26
HAA10
NOMESCO Finland
Biopsy of mammary gland
4.6
56.3
133
291
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
12.3
55.5
55
45
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
9.8
55.4
64
66
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.6
55.4
184
518
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
55.3
376
1577
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
54.4
500
2385
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
2.5
54.0
354
1459
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
6.6
53.8
86
131
B29
ICPC
Lymph/immune mech sympt/complt other
7.0
53.2
81
117
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
7.2
53.2
79
111
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
52.9
872
5089
XX1AD
NOMESCO Finland
Other CT-examination
5.5
52.6
102
188
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
52.4
440
2022
A21
ICPC
Risk factor for malignancy
10.6
52.3
57
54
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
10.2
51.0
57
56
N64.9
ICD-10 Finland
Disorder of breast, unspecified
3.6
50.4
165
460
9706
FHL
Ablation mammae, includes axillary exploration
10.1
49.5
56
56
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
9.3
49.2
59
64
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.4
48.9
123
283
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
11.2
48.4
51
46
5BX04, ,
NOMESCO Finland
76.4
47.0
53
7
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
8.7
46.9
59
68
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
4.0
46.5
132
333
THA00
NOMESCO Finland
Needle biopsy of mamilla
10.7
46.1
50
47
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
45.7
2673
20865
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.9
45.0
220
782
ZSZ10
NOMESCO Finland
Secondary repair operation
11.3
44.8
47
42
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.4
44.0
111
256
A14AB01
ATC
nandrolone; parenteral
10.3
43.9
49
48
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
7.8
43.8
60
77
5BA08, ,
NOMESCO Finland
6.2
43.6
74
120
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.4
43.2
154
454
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.3
43.0
112
265
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
4.2
43.0
116
282
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
42.5
132
355
QCJ00
NOMESCO Finland
Liposuction in upper limb
14.0
42.5
39
28
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
9.5
42.4
50
53
G03FA14
ATC
dydrogesterone and estrogen; systemic
0.4
42.3
174
4685
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.4
42.2
106
244
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
5.6
41.6
79
143
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
6.4
41.3
68
107
A08
ICPC
Swelling
2.0
40.9
504
2672
J01MA12
ATC
levofloxacin; systemic
1.6
40.2
1234
8424
A04AA03
ATC
tropisetron; systemic
7.0
40.2
61
88
ULC02
NOMESCO Finland
Hysteroscopy
1.9
40.1
562
3109
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.8
39.6
119
313
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
39.3
714
4270
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
13.3
39.1
37
28
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
13.9
39.0
36
26
A06AH03
ATC
naloxegol; oral
3.7
38.9
126
349
N62
ICD-10 Finland
Hypertrophy of breast
2.0
38.8
428
2182
WW500
NOMESCO Finland
Blood transfusion
2.3
38.6
293
1290
D05.0
ICD-10 Finland
Lobular carcinoma in situ
7.2
38.5
57
80
3090, ,
Kela drug reimbursment
10.8
38.2
41
38
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
15.1
37.4
33
22
JN6AD
NOMESCO Finland
CT of torso and neck
3.0
37.1
161
536
N05CF01
ATC
zopiclone; oral
1.4
37.0
2424
19118
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
36.7
6673
62535
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
10.6
36.6
40
38
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.6
36.6
121
340
HA1DA
NOMESCO Finland
Restricted mammography
8.9
36.3
45
51
1CD01, ,
NOMESCO Finland
8.8
35.4
44
50
ZXD20
NOMESCO Finland
Day surgery
1.6
35.4
972
6454
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
6.3
35.0
59
95
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
12.6
34.9
34
27
J01DB01
ATC
cefalexin; oral
1.4
33.5
5990
55086
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
4.9
33.4
73
150
SPAT1269
SPAT
Other puncture and/or drainage
4.9
32.9
72
148
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
32.9
380
1969
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.5
32.2
986
6700
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
32.1
296
1411
5702
FHL
Local lymph node removal (eg armpit, groin)
5.5
32.0
61
111
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
4.7
31.9
74
160
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
4.7
31.9
74
160
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.2
31.7
128
409
N05CB02
ATC
barbiturates in combination with other drugs
2.3
31.4
249
1117
Z2446
NOMESCO Finland
Social worker
1.9
31.1
412
2235
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
31.0
517
3011
ZZS55
NOMESCO Finland
Distension of tissue expander
42.4
30.8
38
9
D24
ICD-10 Finland
Benign neoplasm of breast
2.4
30.3
221
956
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.1
30.2
287
1385
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
34.7
29.6
38
11
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
9.8
29.4
34
35
WD705, ,
NOMESCO Finland
50.2
29.3
35
7
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
5.8
29.2
53
92
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.2
29.2
43
60
L95
ICPC
Osteoporosis
1.8
29.0
422
2357
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
5.5
28.9
55
100
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
28.9
451
2575
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
28.0
28.8
39
14
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
3.7
28.7
91
249
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.3
28.5
73
171
WVA30, ,
SPAT
1.8
28.4
475
2767
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
8.0
28.1
38
48
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
9.0
27.7
34
38
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
11.2
27.5
29
26
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
11.2
27.5
29
26
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.8
27.3
436
2507
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
27.1
138
503
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
5.5
26.7
51
93
GA5AA
NOMESCO Finland
Rib X-ray examination
6.1
26.7
46
76
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.6
26.4
88
249
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.2
26.3
102
318
9719
FHL
Other measure in this category
8.3
26.1
34
41
C10AA05
ATC
atorvastatin; oral
0.7
25.3
1887
23280
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.5
25.2
162
663
XX9XW, ,
NOMESCO Finland
4.4
25.2
62
141
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
25.0
189
831
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
21.3
24.7
36
17
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
31.1
23.7
31
10
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
23.5
916
6514
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
5.0
23.4
50
101
A55
ICPC
General and Unspecified, Local injection/infiltration
3.2
23.2
92
291
M05BA04
ATC
alendronic acid; oral
1.5
23.1
765
5267
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
22.9
1047
7668
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
22.6
669
4494
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
4.2
22.6
60
145
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
22.4
255
1316
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.5
22.3
137
549
R18
ICD-10 Finland
Ascites
2.4
22.1
151
636
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
8.1
21.7
29
36
C10AA07
ATC
rosuvastatin; oral
0.8
21.7
1642
20331
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.8
21.5
64
168
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
6.4
21.3
35
55
HA1S1
NOMESCO Finland
Photography of breasts
4.8
21.2
47
98
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.3
21.2
168
755
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
21.2
321
1817
ZX050
NOMESCO Finland
Stereotactic radiotherapy
4.2
20.9
55
132
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
5.9
20.8
37
63
1DB03, ,
NOMESCO Finland
24.2
20.8
29
12
NF3AA
NOMESCO Finland
Femur X-ray examination
2.3
20.7
161
718
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.7
20.6
64
173
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.8
20.5
103
373
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
8.2
20.5
27
33
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
20.4
216
1086
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
6.1
20.3
35
58
156
Kela drug reimbursment
Lapatinib
23.4
19.9
28
12
JN5AN
NOMESCO Finland
Total body isotope imaging
15.3
19.7
32
21
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
73.7
19.7
22
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
19.6
3396
38132
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
7.7
19.5
27
35
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
19.3
432
2718
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
4.2
19.2
50
119
ZX121
NOMESCO Finland
Central venous catheter
5.0
19.2
41
83
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
3.7
19.1
59
159
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
19.1
5005
46040
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
4.1
19.1
52
128
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.8
19.1
97
354
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
6.7
19.1
30
45
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.8
19.0
57
151
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
18.9
1376
10833
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
5.2
18.9
38
73
E66.01
ICD-10 Finland
Obesity due to excess calories
0.6
18.6
291
4895
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.7
18.6
98
365
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.1
18.4
75
242
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.8
18.0
248
1364
TJA10
NOMESCO Finland
Laparocentesis
4.8
18.0
40
84
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
17.8
1182
14991
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
2.7
17.7
91
335
M54.4
ICD-10 Finland
Lumbago with sciatica
0.7
17.6
808
10840
205
Kela drug reimbursment
Chronic hypertension
0.7
17.5
928
12171
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
13.1
17.4
30
23
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
17.3
905
6761
C507, ,
ICD-10 Finland
24.1
17.3
24
10
L01XE07
ATC
[U] lapatinib
24.1
17.3
24
10
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
5.2
17.2
35
68
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
17.0
268
1535
HAA00
NOMESCO Finland
Incision of mammary gland
7.2
16.9
25
35
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
17.4
16.9
26
15
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
16.9
559
3841
TPX15
NOMESCO Finland
Removal of vascular injection port
4.1
16.8
46
114
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.0
16.8
168
829
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.7
16.8
86
316
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
5.7
16.8
31
55
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.1
16.7
164
803
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
15.0
16.6
27
18
LDA00
NOMESCO Finland
Dilatation of cervix uteri
2.8
16.4
80
286
SPAT1324
SPAT
Screening procedure
0.7
16.3
999
12837
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.8
16.1
81
295
WF099
NOMESCO Finland
Other radiotherapy
3.5
16.0
54
155
C08CA01
ATC
amlodipine; oral
0.8
15.9
1825
21635
B04
ICPC
Blood symptom/complaint
3.5
15.9
54
156
C10AA01
ATC
simvastatin; oral
0.8
15.8
1785
21212
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.0
15.7
69
233
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
15.6
475
3208
L02AB01
ATC
megestrol; oral
85.3
15.6
17
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
4.3
15.4
39
91
R06AE07
ATC
cetirizine; oral
1.2
15.4
3260
28997
WZC00, ,
SPAT
0.7
15.3
544
7643
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
15.2
224
1258
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
4.3
15.2
39
92
N05CF02
ATC
zolpidem; oral
1.3
15.0
1263
10111
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
4.3
15.0
38
89
X79
ICPC
Benign neoplasm breast female
10.8
14.9
28
26
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
4.4
14.9
37
85
WW200, ,
SPAT
0.8
14.9
1461
17676
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
14.7
962
12273
ZSZ00
NOMESCO Finland
Primary repair operation
11.3
14.7
27
24
C10AX09
ATC
ezetimibe; oral
0.7
14.6
572
7906
SPAT1097
SPAT
Recording of ECG
0.7
14.6
480
6848
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.6
14.5
80
306
S55
ICPC
Skin, Local injection/infiltration
4.8
14.4
32
67
SPAT1310
SPAT
Counselling related to known health issue
0.8
14.3
1395
16903
Y16
ICPC
Breast symptom/complaint male
17.0
14.3
22
13
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
4.4
14.2
35
80
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.8
14.2
1262
15465
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
11.9
14.0
25
21
1BC02, ,
NOMESCO Finland
14.4
14.0
23
16
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
14.4
14.0
23
16
SPAT1263
SPAT
Sampling
0.8
14.0
2056
23815
9702
FHL
Breast exploration and possible tumor removal
2.1
13.9
132
640
G47.3
ICD-10 Finland
Sleep apnoea
0.7
13.9
812
10530
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.2
13.8
117
543
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.4
13.8
48
141
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
3.9
13.7
40
104
SPAT1301
SPAT
No procedures
0.8
13.6
1392
16790
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
13.6
892
11384
B01AC04
ATC
clopidogrel; oral
0.7
13.5
402
5850
OAB42, ,
SPAT
0.7
13.5
433
6207
N02AA01
ATC
morphine; systemic, rectal
2.3
13.3
98
429
X62
ICPC
Female Genital, Administrative procedure
21.2
13.3
19
9
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
11.5
13.3
24
21
ZZR00
NOMESCO Finland
Flap of skin
2.1
13.2
129
632
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
9.7
13.2
26
27
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
3.1
13.2
55
181
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
10.9
13.0
24
22
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
4.2
12.9
34
82
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
4.2
12.9
33
78
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
3.0
12.8
56
189
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
12.8
776
5922
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
4.7
12.8
29
62
N64.8
ICD-10 Finland
Other specified disorders of breast
2.8
12.8
62
222
LCA10
NOMESCO Finland
Curettage of body of uterus
1.7
12.8
231
1378
G03FA01
ATC
norethisterone and estrogen; systemic
0.8
12.8
865
11003
WZC30, ,
SPAT
0.6
12.8
263
4140
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
9.6
12.7
25
26
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
12.6
340
5044
TQX05
NOMESCO Finland
Skin puncture, unspecified location
4.5
12.6
30
67
B01AA03
ATC
warfarin; systemic
0.7
12.4
495
6827
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
3.8
12.2
37
99
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.3
12.2
846
6582
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.5
12.2
386
2629
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
11.0
12.0
22
20
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
3.0
11.9
50
165
N06AX11
ATC
mirtazapine; oral
1.2
11.9
2409
21171
1XC14, ,
NOMESCO Finland
46.7
11.9
14
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
11.9
846
10695
YX9AW, ,
NOMESCO Finland
3.3
11.9
44
135
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.8
11.8
184
1053
R93.7
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
5.4
11.8
23
43
B01AB04
ATC
dalteparin; parenteral
1.5
11.8
320
2110
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
4.1
11.8
31
75
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
11.7
964
7674
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
11.7
2080
18046
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
30.0
11.6
15
5
ZXD05
NOMESCO Finland
Urgent procedure
1.2
11.6
1735
14796
G03FB08
ATC
dydrogesterone and estrogen; systemic
0.6
11.6
281
4267
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
12.5
11.6
20
16
3065, ,
Kela drug reimbursment
65.0
11.6
13
*
S76
ICPC
Skin infection other
1.5
11.5
313
2063
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
3.4
11.5
40
118
WE198
NOMESCO Finland
Palliative cystotatic therapy
13.6
11.4
19
14
SPAT1262
SPAT
Handing over of treatment supplies
0.7
11.4
548
7336
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
11.3
660
8584
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.7
11.3
467
6407
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
11.3
394
2737
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
11.2
526
7071
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
17.0
11.2
17
10
N61
ICD-10 Finland
Inflammatory disorders of breast
1.8
11.1
158
881
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.7
11.1
181
1051
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
2.8
11.1
55
200
S50
ICPC
Skin, Medication/prescr/renewal
2.8
11.1
53
189
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.8
11.0
1388
16427
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
8.5
11.0
23
27
T90
ICPC
Diabetes non-insulin dependent
0.8
10.9
942
11633
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.6
10.8
235
3653
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
11.9
10.8
19
16
M54.5
ICD-10 Finland
Low back pain
0.8
10.8
2029
23098
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
4.0
10.7
30
76
335
Kela drug reimbursment
Lapatinib
28.0
10.7
14
5
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
28.0
10.7
14
5
SPAT1249
SPAT
Treatment-related counselling outside office
0.8
10.7
1914
21897
R87.8
ICD-10 Finland
Abnormal findings in specimens from female genital organs, other abnormal findings
2.7
10.7
55
204
HA1AT, ,
SPAT
3.7
10.7
33
90
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.6
10.6
194
3140
L01EH03
ATC
tucatinib; oral
60.1
10.6
12
*
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
60.1
10.6
12
*
EB1VA, ,
NOMESCO Finland
0.8
10.6
785
9887
J02AC01
ATC
fluconazole; systemic
1.2
10.5
3350
30525
C50.0
ICD-10 Finland
Malignant neoplasm: Nipple and areola
11.2
10.5
19
17
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.8
10.5
1077
13041
8524/3-C50.2
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast
110.2
10.4
11
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
10.3
479
3503
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.1
10.3
99
484
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
10.3
519
3847
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.5
10.3
306
2058
N05BA06
ATC
lorazepam; systemic, sublingual
1.5
10.2
300
2012
HA1RA, ,
SPAT
1.4
10.2
393
2782
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
4.0
10.2
28
70
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
0.7
10.2
257
3868
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
2.6
10.2
56
215
R4120
NOMESCO Finland
Occupational therapy
1.4
10.2
393
2784
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.0
10.1
105
528
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.5
10.1
34
98
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
4.1
10.1
27
66
SPAT1053
SPAT
Memory test
0.7
10.1
436
5943
AN1
HP
Coronary angiography
0.6
10.0
212
3316
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
11.3
10.0
18
16
TQW11
NOMESCO Finland
Vacuum treatment of wound
1.9
10.0
119
628
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
9.1
10.0
20
22
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
9.9
909
11160
A10BA02
ATC
metformin; oral
0.8
9.9
1114
13362
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
16.7
9.9
15
9
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.7
9.9
569
7417
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.4
9.8
453
3309
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
9.8
492
3647
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
4.9
9.8
21
43
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.8
9.8
1107
13271
NK6SN
NOMESCO Finland
Bone SPECT
10.6
9.8
18
17
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.0
9.7
102
516
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
9.7
169
1002
ZXA10
NOMESCO Finland
Bilateral
1.2
9.7
1161
9658
L04AX03
ATC
methotrexate; systemic
0.7
9.7
367
5109
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.3
9.6
68
294
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.3
9.6
560
4248
128
Kela drug reimbursment
Cancers of female genital organs
1.7
9.6
162
952
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
0.7
9.5
310
4438
SPAT1312
SPAT
General health counselling
0.8
9.5
1419
16546
WX704
NOMESCO Finland
Intubation
1.4
9.4
488
3633
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
9.4
572
7404
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
9.4
478
3551
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
2.5
9.3
58
237
L71
ICPC
Malignant neoplasm musculoskeletal
9.5
9.2
18
19
A26
ICPC
Fear of cancer, NOS
2.7
9.1
47
175
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
4.3
9.1
23
54
E66.00
ICD-10 Finland
Metabolic syndrome
0.6
9.1
127
2199
L04AX01
ATC
azathioprine; systemic
0.5
9.1
86
1669
WX707
NOMESCO Finland
Fiberoscopic intubation
4.0
9.0
25
63
PJW20
NOMESCO Finland
Lymphovenous shunt
15.6
9.0
14
9
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
15.6
9.0
14
9
M79.7
ICD-10 Finland
Fibromyalgia
0.6
9.0
116
2054
N06AB05
ATC
paroxetine; oral
1.4
9.0
373
2678
9710
FHL
Existence of a relapse
18.6
8.9
13
7
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
7.4
8.9
20
27
T82
ICPC
Obesity
0.6
8.9
110
1969
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
1.7
8.8
155
921
E0000UV, ,
ATC
1.2
8.8
2853
25912
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
4.7
8.8
20
43
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.8
8.8
661
8320
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
10.7
8.8
16
15
WPB10
NOMESCO Finland
Making a convalescent care decision
3.1
8.8
35
113
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.4
8.8
56
232
Z50.1
ICD-10 Finland
Other physical therapy
1.4
8.8
322
2262
C01DA14
ATC
isosorbide mononitrate; oral
0.7
8.7
404
5446
R10.1
ICD-10 Finland
Pain localized to upper abdomen
0.8
8.7
881
10708
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.8
8.7
116
636
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
8.7
794
9762
D82
ICPC
Teeth/gum disease
0.8
8.7
1916
21614
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
1.8
8.7
114
623
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.7
8.7
339
4695
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
3.7
8.6
26
70
XX2ET, ,
NOMESCO Finland
4.8
8.6
19
40
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
8.5
457
6026
L01XE10
ATC
[U] everolimus
16.3
8.5
13
8
6117B
ICD-9 Finland
Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]
2.5
8.5
49
193
ZZS50
NOMESCO Finland
Insertion of tissue expander
27.5
8.5
11
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.8
8.4
1264
14759
N05BA04
ATC
oxazepam; oral
1.2
8.4
1794
15746
-1, ,
ICD-10 Finland
1.5
8.4
281
1939
E66
ICD-10 Finland
Obesity
0.6
8.4
170
2680
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
0.5
8.2
65
1340
N85.8
ICD-10 Finland
Other specified noninflammatory disorders of uterus
3.8
8.2
24
63
GD1AD
NOMESCO Finland
Thorax CT examination
1.4
8.2
329
2349
C08CA13
ATC
lercanidipine; oral
0.8
8.2
609
7680
J45.9
ICD-10 Finland
Asthma, unspecified
0.8
8.2
930
11166
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.7
8.2
132
768
ZX100
NOMESCO Finland
Oral
2.1
8.1
74
356
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.5
8.1
272
1878
RD211, ,
NOMESCO Finland
1.5
8.1
249
1692
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
1.5
8.1
267
1840
WPA16
NOMESCO Finland
Extensive demanding palliative symptom assessment and treatment
4.0
8.0
22
55
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
10.0
8.0
15
15
B01AF01
ATC
rivaroxaban; oral
0.7
8.0
456
5958
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
7.7
7.9
17
22
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.8
2256
20261
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.9
7.8
93
493
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
7.8
647
5153
N05AD01
ATC
haloperidol; systemic
1.7
7.8
142
855
158
Kela drug reimbursment
Everolimus
6.9
7.8
18
26
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.0
7.7
33
111
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
7.7
2595
23570
1544, ,
Kela drug reimbursment
45.0
7.7
9
*
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
15.0
7.7
12
8
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
2.0
7.7
75
371
207
Kela drug reimbursment
Chronic arrhythmias
0.8
7.7
496
6369
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
3.4
7.6
26
76
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
2.6
7.6
43
168
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.8
7.6
643
7983
D70.81
ICD-10 Finland
Neutropenia congenital
11.8
7.6
13
11
G43
ICD-10 Finland
Migraine
0.6
7.6
144
2301
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
0.0
7.5
*
223
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
6.1
7.5
19
31
OAB39
NOMESCO Finland
Sexual health guidance
10.0
7.5
14
14
R60.0
ICD-10 Finland
Localized oedema
1.2
7.5
804
6599
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.6
7.5
42
164
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
4.2
7.5
19
45
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
0.7
7.4
187
2812
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
7.4
153
2401
Y77
ICPC
Malignant neoplasm prostate
4.4
7.4
18
41
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
6.4
7.4
18
28
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.8
7.4
531
6725
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.6
7.4
159
2470
HAC99
NOMESCO Finland
Other mastectomy
13.4
7.4
12
9
1AA01, ,
NOMESCO Finland
7.6
7.4
16
21
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
1.9
7.3
82
426
L03.3
ICD-10 Finland
Cellulitis of trunk
2.2
7.3
56
252
YA1WD, ,
NOMESCO Finland
+∞
7.3
7
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.9
7.3
1622
18335
TLC02
NOMESCO Finland
Simple extraction of IUD
1.4
7.3
311
2248
EBA00
NOMESCO Finland
Extraction of tooth
0.9
7.3
1671
18843
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
2.7
7.3
36
132
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
2.8
7.2
34
121
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
15.7
7.2
11
7
T81.9
ICD-10 Finland
Unspecified complication of procedure
1.8
7.2
111
638
M81.8
ICD-10 Finland
Other osteoporosis
1.9
7.2
79
409
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
30.0
7.1
9
*
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
20.0
7.1
10
5
SAA01
NOMESCO Finland
Simple examination of mouth
0.9
7.1
4462
46968
X18
ICPC
Breast pain female
1.7
7.1
120
708
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
6.5
7.1
17
26
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.7
7.1
295
4042
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.8
7.1
1191
13788
E29.1
ICD-10 Finland
Testicular hypofunction
12.0
7.1
12
10
9708
FHL
Radical mastectomy (Halsted), also involves removal of the parasternal gland
12.0
7.1
12
10
HAA01
NOMESCO Finland
Suture of mammary gland
8.8
7.0
14
16
J05AB01
ATC
aciclovir; systemic
1.2
7.0
1513
13265
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
10.0
7.0
13
13
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
10.0
7.0
13
13
C09CA01
ATC
losartan; oral
0.8
7.0
1233
14222
Z30.2
ICD-10 Finland
Sterilization
0.8
7.0
456
5850
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
7.0
404
5264
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
3.3
6.9
25
76
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
0.7
6.9
168
2542
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
6.9
143
2239
OAB50, ,
SPAT
0.7
6.9
241
3397
R4110, ,
SPAT
0.8
6.8
647
7929
B03XA02
ATC
darbepoetin alfa; parenteral
1.8
6.8
92
509
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
4.1
6.8
18
44
QBA10
NOMESCO Finland
Incision of skin of trunk
2.1
6.8
57
267
HA1DG, ,
SPAT
9.3
6.8
13
14
N06AX21
ATC
duloxetine; oral
0.8
6.8
559
6961
R03AC02
ATC
salbutamol; inhalant
0.9
6.8
3381
36172
NE049
NOMESCO Finland
Radiotherapy of methastasis in pelvis, sacrum or coggyx
40.1
6.8
8
*
HAF99
NOMESCO Finland
Other operation for local recurrence of breast cancer
40.1
6.8
8
*
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.1
6.8
61
294
L09
ICPC
Arm symptom/complaint
1.4
6.7
311
2278
HA1DT
NOMESCO Finland
Mammary gland biopsy with MRI guidance
16.7
6.7
10
6
R51.80
ICD-10 Finland
Headache
0.8
6.7
719
8697
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.9
6.7
2587
28144
EB1SA, ,
SPAT
1.4
6.7
297
2163
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
22.5
6.7
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
1.9
6.6
75
392
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
1.8
6.6
90
499
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
3.7
6.6
20
54
A10BJ06
ATC
semaglutide; parenteral
0.6
6.6
135
2120
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.5
6.6
225
1562
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.6
6.6
84
1484
J01MA02
ATC
ciprofloxacin; systemic
1.1
6.5
2309
20985
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
0.7
6.5
179
2642
N46
ICD-10 Finland
Male infertility
8.7
6.5
13
15
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
1.5
6.5
205
1401
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
10.0
6.5
12
12
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.7
6.5
247
3432
A10BK03
ATC
empagliflozin; oral
0.7
6.5
312
4175
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.3
6.5
531
4225
Z50
ICD-10 Finland
Care involving use of rehabilitation procedures
5.7
6.4
17
30
D69.5
ICD-10 Finland
Secondary thrombocytopenia
3.5
6.4
21
60
SFA10
NOMESCO Finland
One-surface restoration
0.9
6.4
3173
34015
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
0.5
6.4
61
1175
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.2
6.4
707
5821
RF210, ,
NOMESCO Finland
1.6
6.4
153
987
K22
ICPC
Risk factor cardiovascular disease
0.7
6.3
162
2422
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
1.4
6.3
318
2363
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
8.1
6.3
13
16
EBA30
NOMESCO Finland
Extraction of root of tooth
0.6
6.3
137
2120
A06AD11
ATC
lactulose; oral
1.2
6.3
792
6611
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
0.6
6.3
91
1552
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.3
6.3
522
4160
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
3.4
6.3
21
61
H02AB04
ATC
methylprednisolone; systemic
0.8
6.2
665
8050
R03DC03
ATC
montelukast; oral
0.8
6.2
840
9933
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.1
6.2
52
244
L15
ICPC
Knee symptom/complaint
0.9
6.2
1425
16101
R01AD58
ATC
fluticasone, combinations; nasal
0.9
6.2
1297
14762
M81
ICD-10 Finland
Osteoporosis without pathological fracture
2.1
6.2
53
251
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.5
6.2
68
1251
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.6
6.1
149
965
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
0.6
6.1
139
2131
A10AA02, ,
ATC
0.5
6.1
43
916
XX2VW
NOMESCO Finland
Radiologic consultation
2.3
6.1
44
194
M48.0
ICD-10 Finland
Spinal stenosis
0.8
6.1
482
6033
L08
ICPC
Shoulder symptom/complaint
0.8
6.1
1192
13642
P20
ICPC
Memory disturbance
0.8
6.1
537
6636
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
2.7
6.1
31
116
J01FF01
ATC
clindamycin; systemic
1.2
6.0
1641
14628
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
8.6
6.0
12
14
A10AB05
ATC
insulin aspart; parenteral
0.7
6.0
179
2599
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
4525
26282
2.84
307.65
9.4
3.1
2.37
2.37
mmol/l
2.98
4323
23776
758
693
12.06
307.65
1.0
1.1
—
—
—
0
0
5805
39759
3.09
307.65
17.6
9.5
3.38
3.99
e9/l
85.47
5351
34432
646
1094
6.37
307.65
1.6
1.3
0.29
0.37
nmol/l
1.64
466
761
5662
36862
3.24
307.65
13.7
6.0
8.98
10.41
umol/l
33.19
5540
34981
2369
7422
4.22
307.65
5.3
3.8
17.03
25.46
ug/l
0.72
1837
5897
2041
1481
18.61
307.65
6.1
2.7
55.56
27.65
u/ml
6.19
1985
1436
1520
6034
2.91
267.30
4.1
3.8
53.69
64.23
u/ml
0.62
1484
5822
6708
53286
3.63
259.17
16.0
8.0
75.83
79.06
u/l
7.18
6604
50476
671
1985
3.62
189.72
1.2
1.2
—
—
—
0
0
4218
31610
1.77
121.66
2.6
2.7
—
—
estimate
—
0
0
4253
32491
1.72
109.30
7.0
6.0
1.22
1.22
mmol/l
3.43
4072
29974
4585
36459
1.67
94.79
8.5
6.6
1.22
1.22
mmol/l
2.15
4001
31491
224
516
4.44
88.83
1.2
1.2
—
—
—
0
0
2517
17445
1.67
87.06
3.8
3.8
95.29
94.57
%
0.85
2465
17007
2387
16732
1.63
76.70
2.2
2.3
—
—
—
0
0
889
4879
1.93
66.28
1.5
1.3
31.34
35.99
iu/l
4.54
734
4288
3984
32114
1.52
65.40
4.2
4.7
35.51
35.92
g/l
4.87
3793
30035
2111
15363
1.52
53.32
3.2
2.9
2.47
2.46
mmol/l
2.75
1928
13816
166
478
3.53
48.30
2.5
1.6
2.57
4.86
ug/l
0.90
107
340
5801
62762
0.66
45.45
3.8
4.3
1.27
1.26
mmol/l
0.30
5295
57770
6197
66058
0.63
44.28
4.6
5.2
4.87
4.86
mmol/l
0.21
5755
61846
6165
65694
0.64
41.90
4.6
5.1
1.62
1.59
mmol/l
8.16
5707
61149
6319
66962
0.63
41.71
5.3
6.0
2.78
2.83
mmol/l
3.93
5835
62466
5877
63107
0.67
39.02
5.5
6.3
38.59
38.91
mmol/mol
2.79
5471
59146
1711
22334
0.70
36.07
3.4
3.9
4.81
7.33
mg/mmol
2.41
884
12495
6076
64655
0.67
35.63
4.8
5.3
5.79
5.84
mmol/l
3.56
5590
59743
270
1198
2.30
34.91
1.2
1.3
—
—
—
0
0
270
1198
2.30
34.91
1.2
1.3
—
—
—
0
0
1003
6749
1.56
34.36
1.7
2.2
0.22
0.21
g/l
3.06
957
6305
1701
22022
0.70
33.54
2.9
3.3
29.67
35.12
mg/l
0.53
916
12489
182
689
2.68
33.09
1.4
1.4
35.99
32.84
g/l
3.04
172
632
369
1915
1.97
31.78
2.4
3.1
5.51
2.00
index
2.21
189
930
1819
23105
0.72
31.41
2.8
3.2
6.59
6.50
mmol/l
0.37
1499
19421
1465
10854
1.44
30.95
1.8
1.9
—
—
—
0
0
49
79
6.24
29.09
1.3
1.3
0.27
0.37
nmol/l
0.35
32
47
1116
8043
1.46
26.96
1.7
1.8
—
—
—
0
0
1049
7559
1.45
25.23
1.8
1.8
—
—
—
0
0
140
541
2.62
24.53
1.4
1.4
29103.78
56178.91
e6/l
0.70
79
277
153
622
2.49
24.15
1.4
1.4
1388.86
2381.57
e6/l
1.81
103
425
1992
16252
1.31
21.60
1.5
1.5
—
—
—
0
0
1371
10596
1.36
21.60
2.8
2.9
3.73
4.32
e6/l
0.90
571
4869
2769
23580
1.28
21.53
4.9
6.4
—
4.46
—
0
5
129
514
2.54
21.29
1.2
1.2
82.22
79.51
u/l
0.08
120
438
270
1445
1.90
21.27
1.5
1.4
35.86
37.44
u/l
0.31
254
1163
6125
64263
0.73
21.18
5.9
6.3
1.96
1.89
mu/l
3.49
5688
60134
127
506
2.54
20.97
1.2
1.2
24.13
21.18
u/l
0.14
114
415
1474
11659
1.33
19.67
3.3
3.1
0.82
0.82
mmol/l
0.03
1394
10923
3743
33316
1.25
19.09
5.2
6.5
27.44
28.57
%
7.85
3573
31509
1190
15182
0.74
18.88
1.6
1.7
29074900.85
31639501.90
pmol/l
0.05
994
12611
6671
63914
1.42
18.36
22.7
15.0
82.37
79.65
ml/min/173m2
31.71
6400
59357
119
491
2.45
18.30
1.3
1.3
6.20
6.45
mmol/l
0.56
113
457
782
5645
1.43
18.29
4.2
2.6
69.92
66.57
ml/min/173m2
2.04
323
2436
3662
32735
1.23
17.17
5.1
6.4
56.80
56.85
%
0.08
3498
31200
178
890
2.02
17.15
1.2
1.2
59.50
59.53
u/l
0.00
166
774
405
2587
1.60
17.03
1.4
1.5
117.87
166.96
pmol/l
1.56
398
2524
2219
18815
1.26
16.78
2.9
3.2
0.44
0.43
e6/l
0.05
1535
13573
1292
15991
0.77
16.01
1.3
1.4
31.73
32.54
iu/ml
0.07
386
5148
2683
23400
1.23
15.31
4.3
3.2
35.11
32.16
u/l
1.43
2555
22053
1463
11925
1.28
15.12
2.7
2.8
1.57
1.58
e6/l
0.01
672
6219
2458
28096
0.81
15.02
3.8
4.2
1.01
0.66
estimate
0.14
510
5972
565
4000
1.45
14.61
1.7
1.7
—
—
—
0
0
3405
30585
1.21
14.03
12.4
11.2
0.00
0.00
e9/l
2.31
2634
24817
2867
25338
1.21
13.96
3.6
4.0
101.38
112.14
e6/l
0.18
1872
17362
1220
14922
0.78
13.37
1.3
1.3
9.62
11.48
u/ml
0.46
477
5955
6794
65760
1.38
13.35
21.6
15.5
21.89
21.70
mg/l
0.19
5817
54002
752
5677
1.36
13.35
5.3
6.9
1.30
1.26
mmol/l
0.41
735
5575
5428
57135
0.81
13.02
4.8
5.1
14.73
14.77
pmol/l
0.55
5014
53119
82
337
2.45
12.85
1.3
1.2
10.47
15.39
u/l
0.56
76
307
378
2535
1.52
12.84
2.6
3.3
996.16
1021.82
u/ml
0.02
321
2151
137
697
1.98
12.69
2.5
3.0
23.91
13.77
index
0.71
102
348
213
1249
1.73
12.55
1.3
1.4
—
—
—
0
0
5775
54876
1.23
12.28
28.2
19.0
13.83
13.64
%
21.59
5750
54172
2469
21714
1.20
12.18
3.0
3.3
92.98
59.36
e6/l
0.37
1773
16325
889
6969
1.31
12.16
2.3
2.4
49.32
39.03
u/l
0.48
755
5844
278
1762
1.60
12.15
1.6
1.6
—
—
—
0
0
1712
19906
0.82
11.53
3.3
3.6
0.49
0.38
estimate
0.09
535
5996
2721
30282
0.84
11.35
1.8
1.9
1.34
1.34
mmol/l
0.02
2306
25364
1910
21919
0.83
11.14
2.0
2.1
156.60
166.53
u/l
0.22
1799
20654
2668
23802
1.19
10.92
3.0
3.4
—
2.00
—
0
12
1395
16455
0.81
10.67
3.9
4.6
1.02
1.20
kg/l
0.80
882
10857
919
11357
0.78
10.67
1.3
1.4
504.08
551.43
titre
0.36
191
2679
27
65
4.16
10.33
1.5
2.5
1.46
1.17
mg/l
0.16
14
46
3986
36874
1.17
10.32
5.3
6.5
0.16
0.19
e9/l
13.18
3364
32262
101
504
2.02
9.97
1.9
1.5
6.28
6.52
u/l
0.05
92
406
314
4517
0.68
9.91
1.6
1.7
—
—
—
0
0
3920
36371
1.16
9.33
5.2
6.4
1.70
1.92
e9/l
17.40
3341
32022
3852
35706
1.16
9.25
2.5
2.6
80.95
2603.23
nmol/l
0.50
3603
32495
1552
17902
0.83
9.19
1.3
1.3
0.91
1.52
u/ml
3.86
346
4891
62
265
2.35
9.04
2.1
3.3
1.95
1.40
%
1.38
62
265
138
2328
0.58
8.96
1.7
1.5
0.16
7.77
iu/ml
0.50
37
437
366
5032
0.71
8.94
1.7
1.8
—
—
—
0
0
736
5866
1.28
8.81
5.4
3.6
1.24
1.24
mmol/l
0.33
693
4996
1530
17608
0.83
8.76
2.0
2.4
318.07
316.36
umol/l
0.27
1322
15453
5020
52680
0.85
8.76
4.0
4.7
12.80
12.72
mm/h
0.14
4668
49534
266
1806
1.49
8.62
3.0
2.8
1.24
1.51
mg/l
12.61
249
1642
535
4146
1.31
7.93
6.7
8.7
94.41
94.01
%
0.68
535
4132
829
10039
0.80
7.88
2.0
2.2
110.52
123.90
ug/g
0.62
634
7892
243
3475
0.69
7.47
1.2
1.3
2.17
1.27
u/ml
0.26
17
299
248
3527
0.69
7.40
1.6
1.9
8.29
7.37
iu/ml
0.15
50
846
235
1613
1.47
7.27
1.3
1.5
—
—
—
0
0
3275
30324
1.14
7.24
8.7
12.8
1.13
1.20
inr
14.56
2593
24972
1832
20508
0.86
7.23
3.8
4.5
0.00
0.00
estimate
2.57
634
7141
424
5515
0.75
7.21
2.5
3.0
10.79
10.34
g/l
1.02
395
5105
175
1136
1.55
7.07
1.4
1.2
18.84
19.56
u/l
0.22
144
922
317
2313
1.39
7.02
1.8
1.9
1.40
1.87
ug/l
0.54
277
2042
240
1667
1.45
7.00
1.3
1.5
—
—
—
0
0
274
1978
1.40
6.49
1.8
2.0
96.12
96.22
%
0.02
261
1896
796
6633
1.22
6.42
3.4
3.3
—
—
—
0
0
3543
37647
0.89
6.02
3.7
4.3
9.44
3.76
estimate
0.62
684
7761
84
471
1.79
6.01
1.4
1.5
10.92
11.49
umol/l
0.35
79
445
472
3742
1.28
5.93
7.0
8.6
24.50
24.47
mmol/l
0.09
457
3676
2371
25785
0.88
5.85
3.2
3.6
29.30
59.71
ng/l
0.92
1596
16949
4154
39355
1.13
5.83
4.1
4.6
6.46
6.57
mmol/l
4.11
4017
37336
334
4357
0.76
5.83
1.9
1.9
1.19
1.35
g/l
1.09
313
4003
162
1086
1.50
5.72
1.4
1.6
—
—
—
0
0
1030
11863
0.85
5.65
1.7
1.7
1138.29
1189.99
nmol/l
0.98
753
9002
3232
34413
0.89
5.46
2.7
3.1
147.32
100.06
ug/l
10.16
3049
32171
409
5133
0.78
5.31
1.3
1.3
213.10
165.63
u/ml
0.63
371
4767
6869
67496
1.23
5.21
20.1
17.9
139.74
139.75
mmol/l
0.23
6789
66278
21
69
3.05
5.21
1.3
1.3
8.19
10.77
%
0.28
16
31
2092
22787
0.89
5.13
2.4
2.6
58.93
61.06
u/l
0.44
1937
21008
42
197
2.14
5.08
1.3
1.8
1361.29
30545.65
e6/l
1.37
24
89
4763
45658
1.12
5.07
4.8
5.1
1874.34
3210.59
e6/l
0.47
50
559
172
2424
0.70
4.98
1.6
1.8
0.24
0.23
g/l
0.47
157
2309
324
2506
1.31
4.97
1.9
2.0
—
—
—
0
0
1791
16256
1.13
4.94
1.7
1.7
1.33
1.09
mg/l
2.02
1410
12687
3521
37194
0.90
4.94
3.7
4.3
0.00
0.00
estimate
2.81
659
7439
735
8608
0.84
4.88
4.8
5.0
34.36
33.28
%
2.00
464
5657
47
896
0.52
4.88
1.1
1.1
28.33
13631.35
iu/ml
—
9
175
149
2141
0.69
4.82
1.3
1.3
1.00
3.35
u/ml
—
8
151
7012
70942
0.80
4.79
34.4
24.1
128.87
132.19
g/l
109.97
6968
70287
3604
37982
0.90
4.76
3.7
4.3
0.00
0.46
estimate
1.30
658
7461
299
2305
1.31
4.72
1.8
1.9
—
—
—
0
0
7012
70934
0.80
4.70
34.5
24.3
38.91
40.21
%
11.46
6966
70229
7012
70934
0.80
4.70
34.2
23.9
4.28
4.41
e12/l
116.09
6908
69343
7013
70940
0.80
4.66
34.3
24.0
6.16
6.56
e9/l
4.34
6911
69345
7012
70927
0.80
4.62
34.2
23.9
92.00
91.19
fl
44.79
6967
70246
39
773
0.50
4.60
1.1
1.0
—
—
—
0
0
59
1032
0.57
4.59
1.3
1.2
25.74
25.13
u/l
0.04
50
894
6871
67617
1.21
4.51
20.3
18.1
3.92
3.94
mmol/l
7.68
6784
66276
239
1799
1.34
4.48
2.1
2.3
3.39
3.63
g/l
2.03
230
1715
182
2492
0.72
4.47
1.5
1.8
1.21
1.21
g/l
0.01
165
2381
7012
70913
0.80
4.47
34.3
24.0
256.09
263.77
e9/l
21.43
6923
69569
150
1046
1.44
4.44
2.1
3.5
2.78
1.42
%
3.21
137
942
205
2752
0.74
4.44
1.2
1.3
27.98
39.28
u/ml
—
8
166
106
1594
0.66
4.38
1.3
1.4
2272.94
1740.24
e6/l
0.18
64
1266
1084
9586
1.15
4.37
2.0
2.0
28.96
29.26
s
0.70
1057
9316
844
7327
1.17
4.34
5.6
7.0
14.35
12.68
kpa
10.48
811
7055
844
7331
1.17
4.32
5.6
7.0
5.12
5.11
kpa
0.11
812
7063
188
2544
0.73
4.30
1.2
1.4
3.00
6.72
u/ml
2.39
25
413
114
758
1.51
4.29
1.3
1.5
—
—
—
0
0
119
799
1.50
4.28
1.4
1.5
—
—
—
0
0
247
1882
1.32
4.28
2.9
2.2
200.45
190.65
%
0.87
240
1785
103
671
1.54
4.26
1.3
1.6
—
—
—
0
0
105
1569
0.66
4.22
1.3
1.4
25.21
33.68
e6/l
0.24
58
1167
1360
15054
0.88
4.21
1.4
1.5
2.22
2.30
g/l
0.52
731
9090
74
1188
0.62
4.15
2.0
2.4
27.70
64.86
ug/min
2.13
42
665
78
1237
0.63
4.14
1.2
1.3
—
87.83
—
0
23
835
7275
1.17
4.11
5.6
7.0
0.67
1.13
mmol/l
3.13
720
6091
659
5632
1.19
4.10
2.8
2.6
66.21
66.52
g/l
0.51
598
5134
44
229
1.93
4.09
1.4
2.0
709.46
3218.52
e6/l
0.54
28
143
28
123
2.28
4.02
1.3
1.2
704.48
158.36
ug/l
0.41
21
70
239
3088
0.77
3.98
1.6
1.6
15.31
17.59
u/ml
0.21
53
671
191
2546
0.74
3.98
1.2
1.3
6.83
5.82
u/ml
0.06
18
268
76
470
1.62
3.95
1.2
1.2
20.21
20.76
u/l
0.04
71
418
162
2210
0.73
3.93
1.3
1.3
229.94
225.36
miu/ml
0.06
74
1061
76
472
1.62
3.89
1.2
1.2
78.87
75.06
u/l
0.17
70
420
94
615
1.53
3.86
1.3
1.6
—
—
—
0
0
633
7352
0.85
3.82
2.3
2.2
409.73
379.02
nmol/l
2.72
583
6802
621
5319
1.18
3.79
1.5
1.7
—
—
—
0
0
30
604
0.49
3.78
1.3
1.5
—
2066.67
—
0
6
104
700
1.49
3.75
1.3
1.2
127.04
114.62
pmol/l
0.30
104
700
501
5901
0.84
3.58
1.2
1.2
150.38
144.30
u/ml
0.14
204
2354
733
6398
1.16
3.54
5.9
7.4
96.18
95.75
%
0.95
710
6185
448
3751
1.21
3.53
1.3
1.4
—
—
—
0
0
52
871
0.59
3.53
1.2
1.1
—
0.46
—
0
9
75
1150
0.65
3.49
1.1
1.2
262.61
281.90
u/ml
0.28
49
716
264
3303
0.79
3.43
1.6
1.7
—
—
—
0
0
209
2689
0.77
3.42
1.5
1.6
—
—
—
0
0
33
616
0.53
3.33
1.8
1.5
24.27
35.72
%
1.14
18
340
134
1822
0.73
3.25
1.6
1.7
293.24
318.84
mu/l
0.54
121
1630
466
5463
0.84
3.18
2.3
2.4
22.39
24.23
au/ml
0.14
48
636
53
855
0.62
3.13
1.3
1.2
7.97
7.45
mmol/l
0.55
46
745
693
6084
1.15
3.12
6.2
7.8
117.82
118.91
g/l
0.97
678
5947
83
1216
0.68
3.12
1.4
1.5
1011.61
1054.24
mu/l
0.10
52
921
934
8368
1.13
3.11
2.5
2.5
9.70
7.29
umol/l
1.67
791
7187
712
6269
1.15
3.08
2.6
3.3
77.55
81.76
ng/l
0.86
623
5344
79
1160
0.68
3.02
2.8
2.0
0.84
0.83
nmol/l
0.08
69
975
81
545
1.49
3.00
1.3
1.5
—
—
—
0
0
81
545
1.49
3.00
1.3
1.5
—
—
—
0
0
81
545
1.49
3.00
1.3
1.5
—
—
—
0
0
134
1791
0.74
2.94
1.2
1.3
535.58
532.71
mg/l
0.02
127
1721
188
1466
1.29
2.87
2.8
3.4
287.17
652.78
u/ml
0.74
174
1310
27
136
1.99
2.84
1.1
1.4
25.98
28.02
g/l
0.25
22
105
54
336
1.61
2.84
1.4
1.6
—
—
—
0
0
54
336
1.61
2.84
1.4
1.6
—
—
—
0
0
54
336
1.61
2.84
1.4
1.6
—
—
—
0
0
432
5043
0.85
2.83
1.2
1.3
74.08
50.13
au/ml
0.89
26
335
54
337
1.61
2.81
1.4
1.6
—
—
—
0
0
295
3558
0.82
2.78
3.9
3.5
1.02
1.02
ratio
0.85
266
3198
59
898
0.65
2.73
1.2
1.2
13.29
45.64
u/ml
—
7
53
214
1709
1.26
2.72
2.2
1.8
1139.03
3794.21
u/l
2.28
69
638
186
1464
1.28
2.67
1.3
1.4
—
—
—
0
0
497
5709
0.86
2.66
3.1
3.4
4.47
4.44
pmol/l
0.35
449
5079
164
2099
0.78
2.65
1.2
1.3
23.06
48.27
u/ml
2.32
16
237
119
1589
0.74
2.63
1.2
1.3
3.60
3.70
mmol/l
0.69
110
1516
89
1235
0.72
2.53
1.5
1.3
0.17
0.27
nmol/l
—
6
83
7
194
0.36
2.52
1.0
1.1
—
—
—
0
0
1096
10034
1.11
2.52
2.1
2.5
22.13
21.61
%
0.67
1043
9272
41
662
0.62
2.50
1.4
1.4
193967.82
120918.59
e6/l
0.24
22
440
70
477
1.47
2.50
1.4
1.5
—
—
—
0
0
586
6619
0.88
2.49
1.5
1.6
1.35
1.38
%
0.59
517
5820
473
5419
0.86
2.47
2.3
2.4
0.58
0.42
e6/l
0.45
449
5131
74
512
1.45
2.45
1.1
1.5
—
—
—
0
0
334
3930
0.84
2.44
1.1
1.1
—
—
—
0
0
248
2044
1.22
2.40
2.2
2.7
—
—
—
0
0
4416
45430
0.93
2.40
3.1
3.3
53.90
43.10
u/l
5.90
4147
42608
211
2588
0.81
2.40
4.0
4.9
0.88
0.89
%
0.21
197
2452
170
2132
0.79
2.36
1.2
1.2
124.00
139.36
titre
0.10
25
203
57
840
0.68
2.30
1.6
1.6
55.85
54.57
%
0.09
34
503
266
3160
0.84
2.20
2.1
2.2
42.74
40.29
u/l
1.15
245
2838
28
479
0.58
2.19
1.5
1.6
5.50
5.77
u/l
0.19
21
413
44
674
0.65
2.17
1.3
1.4
—
—
—
0
0
10
239
0.42
2.13
1.6
3.1
24.20
27.45
umol/l
—
5
181
146
1153
1.27
2.11
1.8
2.6
38.75
32.38
umol/l
1.91
129
1045
58
831
0.70
2.05
1.4
1.4
—
—
—
0
0
32
191
1.68
2.05
9.7
3.2
88.24
130.44
ng/l
0.37
17
59
1727
18289
0.93
2.05
2.2
2.4
2.69
2.86
mg/l
2.21
1493
15893
79
1074
0.73
2.05
1.2
1.3
134.63
157.13
au/ml
0.69
16
296
20
367
0.54
2.03
1.2
1.3
129.00
130.17
nmol/l
0.05
20
367
45
674
0.67
2.02
1.1
1.2
—
—
—
0
0
407
3561
1.15
2.02
3.0
3.8
24.58
24.50
mmol/l
0.19
398
3518
737
8097
0.90
2.00
7.3
6.6
—
—
—
0
0
1177
10936
1.09
2.00
2.0
2.4
2.38
2.38
g/l
0.06
1109
10064
517
5795
0.88
1.99
1.5
1.5
—
—
—
0
0
239
2831
0.84
1.95
3.8
4.7
1.48
1.58
%
1.24
224
2690
11
45
2.45
1.92
1.2
1.1
14.05
10.92
mg/l
0.34
11
39
46
677
0.68
1.91
1.3
1.4
1.16
1.17
ratio
0.04
23
386
40
259
1.55
1.88
1.8
1.6
0.41
0.41
ug/l
0.02
35
184
96
730
1.32
1.88
1.1
1.1
—
—
—
0
0
153
1237
1.24
1.85
1.3
1.4
—
—
—
0
0
3058
31679
0.94
1.85
2.1
2.1
98.69
99.68
pmol/l
0.49
1510
15412
0
54
0.00
1.85
0.0
1.0
—
8.18
—
0
54
109
1392
0.78
1.84
3.6
3.4
0.78
0.82
nmol/l
0.50
92
1127
282
3269
0.86
1.80
1.5
1.5
—
—
—
0
0
38
247
1.54
1.78
1.4
1.7
—
—
—
0
0
38
247
1.54
1.78
1.4
1.7
—
—
—
0
0
47
677
0.69
1.76
1.3
1.4
1.27
1.20
ratio
0.19
24
387
47
677
0.69
1.76
1.3
1.4
0.99
0.97
ratio
0.12
24
386
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
452
5054
0.89
1.71
2.1
2.3
3.17
6.09
ug/l
17.29
376
4344
212
2503
0.84
1.71
1.8
2.0
5.47
9.22
iu/l
0.48
84
1039
46
315
1.46
1.70
1.1
1.1
—
—
—
0
0
17
305
0.56
1.65
9.9
12.5
648.53
5072.67
nmol/l
0.53
17
297
156
1888
0.82
1.65
1.4
1.4
—
—
—
0
0
28
440
0.63
1.63
2.1
2.6
649.36
1074.16
u/ml
1.51
28
433
187
2221
0.84
1.63
1.8
2.1
146.59
575.84
ug/l
3.75
175
2084
11
225
0.49
1.62
1.0
1.1
—
—
—
0
0
25
401
0.62
1.60
1.2
1.5
54.14
57.75
ug/l
0.23
25
401
22
128
1.72
1.59
1.8
1.7
—
—
—
0
0
318
3617
0.87
1.59
1.9
2.2
0.02
0.05
estimate
0.27
82
1165
27
425
0.63
1.59
1.6
2.4
509.53
498.36
e6/l
0.04
19
339
23
376
0.61
1.59
1.1
1.1
1.00
1.16
u/l
1.19
12
164
54
743
0.72
1.58
1.1
1.1
—
1.23
—
0
7
5565
54751
1.06
1.58
29.5
20.1
329.96
330.43
g/l
4.54
5541
54481
43
614
0.70
1.57
1.2
1.5
—
—
—
0
0
208
2436
0.85
1.55
1.4
1.4
277.43
284.76
ug/g
0.20
127
1380
43
612
0.70
1.55
1.3
1.3
0.51
1.28
u/ml
1.21
24
352
195
2294
0.85
1.54
1.3
1.5
0.34
0.32
mg/l
0.20
86
911
34
505
0.67
1.53
1.6
1.8
—
—
—
0
0
31
468
0.66
1.52
1.2
1.1
—
—
—
0
0
7
27
2.59
1.51
1.0
1.2
518.71
218.45
u/l
—
7
22
53
724
0.73
1.50
1.3
1.5
62.86
59.74
ug/l
0.20
32
558
63
837
0.75
1.49
4.0
5.7
343.16
372.67
umol/l
0.94
55
732
14
255
0.55
1.46
1.1
1.1
—
—
—
0
0
217
1865
1.17
1.45
2.1
2.4
0.00
0.00
g/l
-0.00
195
1743
22
353
0.62
1.43
1.1
1.2
158.05
143.01
mmol/24h
0.30
22
353
6
22
2.73
1.43
1.0
1.0
362.17
293.47
nmol/l
—
6
22
51
692
0.74
1.40
1.2
1.1
—
104.81
—
0
8
84
1064
0.79
1.40
1.5
1.3
0.19
0.20
nmol/l
0.20
64
798
126
1526
0.82
1.39
3.0
2.9
1.47
1.51
mmol/l
0.17
120
1489
25
386
0.65
1.39
1.5
1.2
0.64
0.59
ratio
0.38
16
232
40
563
0.71
1.38
1.2
1.2
—
—
—
0
0
33
222
1.49
1.38
1.0
1.3
—
—
—
0
0
1568
14935
1.06
1.37
2.4
2.7
9.16
7.31
e6/l
0.91
1432
13564
171
2011
0.85
1.37
2.2
2.2
10.85
11.70
mg/l
0.66
164
1874
84
1061
0.79
1.37
1.4
1.3
416.14
352.14
pmol/l
0.18
72
920
120
983
1.22
1.37
6.4
5.0
1.94
2.33
ug/l
0.44
91
765
12
223
0.54
1.36
1.5
1.8
8.72
8.90
ug/l
0.06
12
223
88
1102
0.80
1.34
1.4
1.7
—
—
—
0
0
0
40
0.00
1.32
0.0
1.0
—
1.66
—
0
19
230
2003
1.15
1.32
2.1
2.3
0.00
0.00
g/l
0.37
195
1749
40
557
0.72
1.31
1.2
1.2
—
—
—
0
0
90
720
1.25
1.29
4.7
4.5
21.70
22.48
%
0.19
43
327
36
251
1.44
1.28
1.4
1.8
—
—
—
0
0
466
5105
0.91
1.27
2.3
2.9
147.88
168.83
ng/l
0.87
427
4680
8
35
2.29
1.26
1.6
1.3
—
—
—
0
0
47
633
0.74
1.26
1.0
1.1
—
—
—
0
0
19
304
0.62
1.25
2.5
2.2
—
—
—
0
0
68
529
1.29
1.23
4.0
3.0
1.27
0.77
ug/l
0.46
45
319
1380
13141
1.06
1.23
3.4
3.8
147.34
267.00
ng/l
2.17
1057
9717
10
49
2.04
1.21
1.1
1.1
7.70
13.43
u/l
—
10
49
25
373
0.67
1.21
1.2
1.5
1.48
1.29
nmol/l
0.34
17
279
23
349
0.66
1.21
1.2
1.1
1385.90
1553.04
miu/ml
0.34
23
349
158
1843
0.85
1.19
1.6
1.6
10082.34
11143.89
e6/l
0.15
100
1278
12
212
0.57
1.17
1.1
1.1
—
—
—
0
0
236
2083
1.14
1.15
2.0
2.3
0.01
0.02
g/l
0.64
205
1869
761
7130
1.07
1.12
3.2
4.4
270.60
244.62
u/l
1.58
727
6737
8
40
2.00
1.12
1.1
1.3
208.14
73.52
pmol/l
—
8
40
22
330
0.67
1.11
1.8
2.8
42.71
42.91
%
0.02
14
196
126
1487
0.84
1.11
1.4
1.8
—
—
—
0
0
23
151
1.52
1.11
1.2
1.1
—
47.20
u/ml
—
0
5
88
717
1.23
1.11
1.3
1.2
—
—
—
0
0
1245
11858
1.06
1.11
2.2
2.5
13.26
12.86
umol/l
1.15
1184
10996
40
539
0.74
1.11
1.1
1.4
2.12
2.13
mmol/l
0.02
34
509
64
503
1.27
1.10
1.6
1.7
—
—
—
0
0
55
707
0.78
1.09
1.2
1.1
—
5.02
—
0
9
24
160
1.50
1.09
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
350
0.68
1.06
1.1
1.1
—
—
—
0
0
247
2766
0.89
1.06
2.7
3.0
26.04
25.45
mmol/l
1.98
237
2687
239
2126
1.13
1.05
1.2
1.3
—
—
—
0
0
43
568
0.76
1.05
1.4
1.8
8.47
7.10
umol/l
0.11
31
416
282
3132
0.90
1.05
3.3
3.7
48.63
47.42
%
0.35
276
3090
275
2469
1.12
1.04
2.0
2.4
0.60
0.74
g/l
0.27
233
2112
13
216
0.60
1.04
1.0
1.1
—
—
—
0
0
69
554
1.25
1.01
6.3
6.7
17.45
67.28
ug/l
0.80
46
333
362
3304
1.10
1.01
2.2
2.8
0.60
0.62
%
0.80
362
3290
164
1878
0.87
1.00
1.2
1.5
11.84
15.28
iu/ml
—
5
49
7
35
2.00
1.00
1.0
1.2
—
—
—
0
0
22
320
0.69
0.98
1.4
2.0
86.83
155.27
umol/l
1.60
12
168
203
2286
0.88
0.97
2.7
3.3
29.80
37.97
mg/l
1.31
175
1946
0
30
0.00
0.97
0.0
1.0
—
134.39
—
0
18
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
23
330
0.70
0.96
1.0
1.1
—
—
—
0
0
0
32
0.00
0.95
0.0
1.3
—
2.06
—
0
25
65
800
0.81
0.93
1.0
1.2
—
—
—
0
0
639
6001
1.07
0.92
2.7
3.6
2.17
1.99
mmol/l
0.54
569
5325
228
2044
1.12
0.92
1.1
1.2
—
—
—
0
0
27
373
0.72
0.91
1.4
1.3
—
—
—
0
0
54
677
0.80
0.91
5.6
4.3
6.76
7.74
mmol/l
1.64
47
565
28
201
1.39
0.91
1.1
1.2
4.79
9.40
pmol/l
1.95
11
67
6968
69316
1.08
0.90
20.2
12.4
24.49
24.02
u/l
1.01
6872
67407
554
5182
1.07
0.89
2.4
3.0
4.54
4.48
kpa
0.31
530
5047
117
1358
0.86
0.89
3.5
3.7
19.35
24.09
mg/l
1.26
86
950
181
2037
0.89
0.88
2.5
2.7
25.72
25.19
mmol/l
1.03
175
2008
382
3523
1.09
0.88
6.7
9.0
15.87
15.72
%
0.50
371
3398
358
3885
0.92
0.87
2.5
3.3
5.20
5.19
kpa
0.03
335
3704
1994
20545
0.96
0.87
1.6
1.7
21.05
21.32
nmol/l
0.36
1715
17302
657
6190
1.07
0.87
2.7
3.5
5.85
5.82
kpa
0.28
631
6044
205
2286
0.89
0.86
2.7
3.3
32.15
73.23
mg/l
1.07
176
1948
361
3327
1.09
0.85
2.2
2.9
1.12
1.21
%
1.30
361
3312
49
388
1.26
0.84
1.4
1.4
—
—
—
0
0
35
457
0.76
0.83
1.1
1.1
—
—
—
0
0
137
1562
0.87
0.83
1.8
2.2
125.41
126.51
g/l
0.22
94
1174
6
112
0.54
0.83
1.8
1.8
—
—
—
0
0
13
202
0.64
0.82
3.0
3.9
11.96
10.44
kpa
0.45
13
202
113
976
1.16
0.82
1.4
1.4
—
—
—
0
0
176
1972
0.89
0.82
1.0
1.1
1.22
7.96
eliau/ml
4.08
20
251
1813
17574
1.04
0.81
3.4
4.2
0.00
0.44
0.96
12
186
30
223
1.35
0.81
1.1
1.1
91.31
95.89
%
0.17
13
91
13
201
0.65
0.81
3.0
3.9
4.99
5.03
kpa
0.06
13
201
57
697
0.82
0.80
1.2
1.6
—
—
—
0
0
34
259
1.31
0.79
1.1
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
86.31
—
0
26
257
2812
0.91
0.77
1.5
1.7
1.68
1.59
g/l
0.62
216
2405
5
98
0.51
0.77
1.2
2.6
—
—
—
0
0
258
2821
0.91
0.77
1.6
1.7
—
—
—
0
0
7007
69756
1.07
0.76
29.4
20.1
68.43
70.26
umol/l
9.78
6958
68989
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
227
2063
1.10
0.75
1.1
1.2
—
—
—
0
0
11
67
1.64
0.75
12.6
12.5
4.38
4.73
mmol/l
0.30
11
67
110
1261
0.87
0.74
4.8
6.6
105.43
104.94
mmol/l
0.46
97
1134
110
1260
0.87
0.74
4.8
6.6
11.01
11.07
mmol/l
0.08
97
1132
7
38
1.84
0.73
1.7
2.2
—
—
—
0
0
76
895
0.85
0.73
1.2
1.2
—
35.00
—
0
12
44
352
1.25
0.72
1.5
1.5
—
—
—
0
0
30
228
1.32
0.72
1.1
1.1
91.08
92.03
%
0.05
13
89
6
108
0.56
0.72
2.0
1.9
—
—
—
0
0
37
290
1.28
0.72
1.1
1.0
99.21
93.50
%
0.76
29
226
94
1085
0.86
0.71
1.1
1.1
2.48
2.98
0.22
15
162
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
20
275
0.73
0.70
1.4
1.2
—
—
—
0
0
51
417
1.22
0.70
1.1
1.1
1.04
1.05
ratio
0.86
39
338
13
193
0.67
0.69
1.5
2.1
0.92
1.13
ug/l
0.36
13
185
68
800
0.85
0.67
2.0
2.0
32.59
32.14
pg
0.41
68
795
14
203
0.69
0.67
1.3
2.1
34.90
3.86
ug/l
—
9
116
51
420
1.22
0.66
1.8
1.6
—
—
—
0
0
15
214
0.70
0.66
3.0
2.6
0.62
0.61
mmol/l
0.16
15
214
106
1204
0.88
0.65
1.1
1.1
3.34
2.97
u/ml
0.17
54
573
184
2023
0.91
0.65
2.7
3.2
1.84
5.03
ratio
1.68
96
1174
531
5602
0.94
0.64
2.1
2.5
73.11
70.80
e9/l
0.66
359
4061
114
1286
0.88
0.64
1.4
1.4
—
—
—
0
0
226
2076
1.09
0.63
1.1
1.1
0.55
0.61
ratio
0.79
39
303
13
87
1.49
0.63
1.1
1.1
—
—
—
0
0
46
557
0.82
0.63
2.1
2.1
3.25
1.90
u/field
0.67
24
296
301
3231
0.93
0.62
2.2
3.2
2.22
2.05
mmol/l
0.33
238
2469
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
199
1822
1.09
0.61
2.5
3.1
0.39
0.37
iu/ml
0.28
102
1012
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
46
554
0.83
0.60
1.1
1.2
120.00
159.09
titre
—
6
88
8
51
1.57
0.60
1.6
1.5
0.48
0.48
e9/l
—
8
51
0
21
0.00
0.60
0.0
4.5
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
139
1253
1.11
0.58
1.4
1.4
—
—
—
0
0
45
373
1.21
0.57
1.5
1.4
—
—
—
0
0
77
883
0.87
0.57
2.3
2.2
30.14
26.04
mg/l
0.22
29
328
66
570
1.16
0.54
1.9
2.7
36.45
24.63
mg/l
0.89
40
409
4653
46990
0.97
0.54
4.5
5.0
0.83
2.38
5.18
11
73
2017
20595
0.97
0.53
2.9
3.2
0.00
0.06
4.72
30
478
179
1646
1.09
0.52
1.8
2.0
5.12
5.11
mmol/24h
0.00
163
1470
127
1401
0.90
0.52
1.1
1.1
2.50
1.30
u/ml
0.81
69
706
9
133
0.68
0.51
1.3
2.0
4.44
5.92
ug/l
—
9
133
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
11
157
0.70
0.51
1.0
1.4
—
—
—
0
0
59
681
0.87
0.50
1.8
2.2
3.98
4.00
mmol/l
0.09
59
676
22
280
0.78
0.49
4.0
4.1
—
—
—
0
0
59
680
0.87
0.49
1.8
2.2
104.24
105.53
mmol/l
1.19
59
675
149
1364
1.09
0.49
1.5
1.6
—
—
—
0
0
39
465
0.84
0.49
1.1
1.1
1.08
10.13
nmol/l
—
7
84
268
2513
1.07
0.49
1.6
1.7
2.88
4.24
mg/l
2.42
218
1926
93
831
1.12
0.48
1.1
1.2
—
—
—
0
0
45
528
0.85
0.47
1.1
1.1
—
—
—
0
0
25
311
0.80
0.47
1.8
2.5
18.46
128.97
ug/l
0.68
25
295
261
2449
1.07
0.47
2.0
2.3
10.08
10.01
g/l
0.09
226
2155
746
7198
1.04
0.47
2.0
2.0
3.21
3.30
ratio
1.31
554
5486
72
814
0.88
0.46
1.2
1.4
273.17
275.28
mosm/kgh2o
0.31
46
616
36
300
1.20
0.46
1.3
1.6
—
—
—
0
0
36
300
1.20
0.46
1.3
1.6
—
—
—
0
0
105
1160
0.90
0.46
1.1
1.1
0.33
0.87
u/ml
2.03
44
460
29
353
0.82
0.46
1.6
1.8
—
—
—
0
0
11
77
1.43
0.45
1.5
1.2
98.35
53.40
ng/l
—
6
47
287
2707
1.06
0.45
1.9
2.3
3.05
2.89
g/l
1.76
252
2447
11
152
0.72
0.44
1.2
1.3
0.75
32.84
mg/l
—
6
109
62
704
0.88
0.44
1.0
1.1
—
—
—
0
0
59
672
0.88
0.43
1.8
2.2
1.21
1.21
mmol/l
0.06
59
667
6
92
0.65
0.42
1.0
1.0
—
—
—
0
0
338
3553
0.95
0.42
1.4
1.5
—
—
—
0
0
109
994
1.10
0.41
1.1
1.1
119.59
121.65
%
0.34
100
894
35
413
0.85
0.41
1.4
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
6.1
—
362.33
—
0
15
41
477
0.86
0.41
1.7
2.0
—
—
—
0
0
1993
20269
0.98
0.39
2.6
3.0
1062.41
1098.97
ng/l
0.13
1724
17372
90
991
0.91
0.39
1.1
1.1
1.45
2.87
u/ml
1.31
40
444
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
9.98
—
0
12
0
19
0.00
0.39
0.0
1.0
—
0.07
—
0
7
39
453
0.86
0.39
1.1
1.0
34.80
42.48
ng/l
0.98
29
317
11
80
1.38
0.38
1.0
1.8
—
—
—
0
0
5
36
1.39
0.38
15.2
8.4
—
—
—
0
0
90
818
1.10
0.38
5.4
5.2
155.14
127.20
u/ml
0.11
27
269
27
323
0.84
0.38
1.1
1.2
6.93
11.57
mm/h
3.13
27
323
27
323
0.84
0.38
1.3
1.3
—
—
—
0
0
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
8
114
0.70
0.37
1.0
1.4
—
5318.18
—
0
11
39
450
0.87
0.36
1.1
1.0
818.70
735.80
ng/l
0.43
27
310
86
944
0.91
0.36
1.1
1.1
2.61
2.83
u/ml
0.07
38
374
22
267
0.82
0.36
1.3
1.3
—
—
—
0
0
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
88
802
1.10
0.36
1.2
1.5
—
—
—
0
0
5
78
0.64
0.35
1.2
1.1
—
—
—
0
0
19
153
1.24
0.35
1.2
1.1
—
—
—
0
0
9
124
0.73
0.35
2.2
2.9
317.78
3018.05
u/l
—
9
116
97
1056
0.92
0.35
1.1
1.2
3.03
3.67
u/ml
0.50
40
451
176
1872
0.94
0.35
1.3
1.3
—
—
—
0
0
192
2036
0.94
0.35
2.1
3.4
25.30
25.16
mmol/l
0.31
169
1844
17
211
0.81
0.34
1.5
1.3
98.42
117.67
nmol/l
0.39
12
148
39
447
0.87
0.34
1.1
1.0
295.87
350.94
ng/l
1.07
30
316
20
163
1.23
0.34
1.3
1.1
—
—
—
0
0
30
350
0.86
0.33
1.1
1.2
—
—
—
0
0
29
339
0.85
0.33
1.4
2.1
6.79
8.22
mmol/l
1.73
29
339
34
392
0.87
0.32
1.1
1.2
—
85.50
—
0
28
60
665
0.90
0.32
1.0
1.2
—
—
—
0
0
65
588
1.11
0.32
3.3
3.7
—
—
—
0
0
553
5365
1.03
0.30
1.7
1.7
3.46
3.56
mmol/l
1.16
366
3687
32
277
1.16
0.30
1.2
1.1
42.78
584.93
ng/l
—
9
68
78
850
0.92
0.30
1.1
1.1
0.11
0.30
u/ml
0.65
30
247
29
249
1.17
0.30
2.0
2.1
14.29
101.64
ug/min
—
7
44
136
1448
0.94
0.30
1.3
1.4
57.51
60.87
mmol/l
0.42
101
1152
73
668
1.09
0.29
2.0
3.5
59.15
56.20
%
0.60
64
580
35
398
0.88
0.29
1.2
1.5
70.23
72.46
umol/l
0.31
35
398
8
64
1.25
0.27
3.3
2.8
34.75
37.18
umol/l
—
8
54
62
677
0.91
0.26
1.0
1.2
—
—
—
0
0
62
676
0.92
0.26
1.0
1.2
—
—
—
0
0
5
74
0.68
0.26
2.0
2.0
2.16
1.60
mg/l
—
5
62
54
492
1.10
0.25
1.1
1.1
16.94
17.66
u/ml
0.05
17
199
9
76
1.18
0.24
1.0
1.1
—
—
—
0
0
6
83
0.72
0.24
3.5
2.7
0.17
0.80
u/field
—
6
83
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
102
961
1.06
0.22
1.3
1.4
—
—
—
0
0
91
967
0.94
0.21
3.1
2.8
13.23
13.27
%
0.16
91
953
0
10
0.00
0.21
0.0
1.0
—
1.50
—
0
10
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
4.9
—
0.17
—
0
11
61
565
1.08
0.21
2.0
2.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
375
3853
0.97
0.20
5.1
6.5
24.77
24.76
mmol/l
0.01
360
3688
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
60
645
0.93
0.20
1.0
1.2
—
—
—
0
0
189
1963
0.96
0.19
1.1
1.2
3.59
4.03
0.31
26
250
53
572
0.93
0.19
1.3
1.5
19.43
23.11
u/ml
—
7
104
101
957
1.06
0.19
1.3
1.4
—
—
—
0
0
10
81
1.23
0.18
1.1
1.1
—
—
—
0
0
12
143
0.84
0.18
1.2
1.4
1.18
1.18
mmol/l
0.09
12
143
32
353
0.91
0.18
2.2
1.9
2.32
2.32
u/field
0.00
22
248
104
1091
0.95
0.17
1.1
1.1
2.04
1.10
u/ml
0.58
58
509
5
68
0.74
0.17
1.0
1.1
—
—
—
0
0
5
68
0.74
0.17
1.2
1.1
76.80
80.47
titre
—
5
68
96
915
1.05
0.16
1.3
1.4
—
—
—
0
0
17
193
0.88
0.15
1.1
1.1
—
—
—
0
0
19
168
1.13
0.15
1.5
1.3
49.10
40.19
%
—
10
117
29
264
1.10
0.15
1.2
1.2
112.96
113.00
%
0.00
24
234
96
917
1.05
0.15
1.3
1.4
—
—
—
0
0
35
379
0.92
0.15
1.1
1.1
—
—
—
0
0
40
371
1.08
0.15
1.1
1.1
—
—
—
0
0
31
284
1.09
0.15
1.2
1.2
0.32
0.31
g/l
0.68
24
230
112
1075
1.04
0.14
1.1
1.2
1.61
2.89
u/ml
2.46
38
376
9
83
1.08
0.14
2.0
1.2
—
—
—
0
0
19
169
1.12
0.14
1.1
1.1
—
—
—
0
0
7
89
0.79
0.14
1.0
1.5
—
1.02
—
0
6
292
2852
1.02
0.14
1.9
2.3
4.24
4.29
g/l
0.55
257
2589
102
978
1.04
0.14
1.3
1.4
—
—
—
0
0
292
2857
1.02
0.13
1.9
2.3
7.47
7.51
g/l
0.17
257
2596
106
1020
1.04
0.13
1.0
1.1
1.75
3.56
eliau/ml
1.91
49
466
890
8798
1.01
0.13
3.6
5.0
1.02
1.04
mmol/l
1.39
830
8078
95
912
1.04
0.13
1.3
1.4
—
—
—
0
0
291
2850
1.02
0.12
1.9
2.3
3.62
3.63
g/l
0.02
255
2590
77
804
0.96
0.12
6.1
6.8
12.68
12.56
mg/l
0.08
72
748
16
143
1.12
0.11
1.0
1.1
—
—
—
0
0
129
1252
1.03
0.11
2.6
3.3
2.43
2.67
mmol/l
0.54
95
897
64
613
1.04
0.10
3.6
1.8
11.35
6.20
nmol/l
2.86
55
519
31
331
0.94
0.10
1.2
1.4
3.14
3.55
umol/l
0.32
25
298
33
351
0.94
0.10
1.1
1.6
—
—
—
0
0
5
45
1.11
0.09
1.2
1.3
163.20
608.55
u/l
—
5
40
5
45
1.11
0.09
1.0
1.9
—
—
—
0
0
10
87
1.15
0.09
1.3
1.3
—
—
—
0
0
47
493
0.95
0.09
1.2
1.4
—
616.25
—
0
32
5
48
1.04
0.09
1.0
1.0
0.00
0.35
u/ml
—
5
36
5
48
1.04
0.09
2.6
1.5
30.60
39.03
%
—
5
32
12
107
1.12
0.08
1.1
1.1
76.61
7.09
u/ml
0.51
12
107
12
107
1.12
0.08
1.3
1.1
—
—
—
0
0
5
60
0.83
0.08
1.4
1.0
—
—
—
0
0
5
63
0.79
0.08
1.4
1.0
—
—
—
0
0
107
1042
1.03
0.08
1.1
1.1
—
—
—
0
0
15
164
0.91
0.08
1.1
1.1
13.81
31.96
iu/ml
1.67
15
164
18
166
1.08
0.07
1.2
1.1
—
—
—
0
0
389
3847
1.01
0.07
2.4
3.0
124.58
127.46
g/l
2.19
377
3740
9
84
1.07
0.07
1.0
1.1
—
—
—
0
0
10
89
1.12
0.06
1.0
1.0
—
—
—
0
0
28
295
0.95
0.06
1.2
2.0
41.00
40.26
g/l
0.32
28
295
237
2338
1.01
0.06
1.2
1.3
—
—
—
0
0
77
751
1.03
0.05
1.1
1.1
103.42
95.96
%
1.68
71
710
14
151
0.93
0.05
1.2
1.1
—
—
—
0
0
44
455
0.97
0.05
1.3
1.3
—
—
—
0
0
17
159
1.07
0.05
1.1
1.1
—
—
—
0
0
4152
41562
1.00
0.03
2.9
3.0
—
—
—
0
0
25
240
1.04
0.03
1.1
3.9
6767.70
954.58
mg/l
0.40
20
163
21
218
0.96
0.02
1.5
1.5
—
—
—
0
0
56
569
0.98
0.02
1.1
1.2
—
—
—
0
0
29
298
0.97
0.02
1.6
1.5
14.60
15.24
pmol/l
0.36
23
247
11
117
0.94
0.01
2.0
1.8
60.16
59.91
pmol/l
0.00
11
101
128
1289
0.99
0.01
1.7
5.0
199.89
608.09
iu/ml
—
9
168
31
317
0.98
0.01
1.2
1.3
—
—
—
0
0
31
317
0.98
0.01
1.2
1.3
—
—
—
0
0
125
1257
0.99
0.01
1.1
1.1
17.14
14.42
au/ml
0.15
25
274
515
5157
1.00
0.00
4.8
6.7
7.95
9.14
mmol/l
3.63
492
4932
44
446
0.99
0.00
1.3
1.3
—
—
—
0
0
12
119
1.01
0.00
1.2
1.1
—
—
—
0
0
31
307
1.01
0.00
1.5
1.4
81.00
216.58
nmol/24h
0.72
31
307
17
167
1.02
0.00
1.1
1.1
—
—
—
0
0
16
155
1.03
0.00
1.1
1.1
0.43
0.65
umol/24h
—
7
69
19
191
0.99
0.00
1.1
1.1
—
—
—
0
0
62
617
1.00
0.00
1.1
1.1
8.37
8.35
iu/ml
0.00
17
158
17
169
1.01
0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
7
70
1.00
-0.00
1.3
1.1
1.70
1.59
umol/24h
—
7
70
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
86
0.93
-0.00
1.3
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
42.52
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
96
0.94
-0.00
1.1
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
298.40
—
0
5
5
49
1.02
-0.00
7.4
6.7
—
—
—
0
0
9
91
0.99
-0.00
1.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L02BA – L02BA Anti-estrogens
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).